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Background: Cigarette smoking has been associated with acute myeloid leukemia (AML)
but hypothesis on the association between maternal smoking during pregnancy and child-
hood leukemia remains unclear.Objectives:To investigate the association between mater-
nal exposure to tobacco smoking during pregnancy and early age (<2 year) leukemia (EAL).
Methods: A hospital-based multicenter case-control study aiming to explore EAL risk fac-
torswas carried out in Brazil during 1999–2007. Datawere collected by direct interviewwith
the biological mothers using a standardized questionnaire.The present study included 675
children (193 acute lymphoid leukemia – ALL, 59 AML and 423 controls), being the latter
age frequencymatched and paired by area of residencewith the cases. Unconditional logis-
tic regression was performed, and odds ratios (OR) on the association between tobacco
smoking (3months before pregnancy, during pregnancy, and 3months after delivery) and
EAL were ascertained after adjustment for selected variables (maternal age at birth and
education, birth weight, infant skin color, and oral contraceptives use during pregnancy).
Results: Smoking was reported by 17.5% of case mothers and 20.6% of controls. Among
women who reported to have smoked 20 or more cigarettes during the index pregnancy,
an adjusted OR=5.28 (95% CI 1.40–19.95) for ALL was observed. Heavy smoking during
breastfeeding yielded an adjusted risk estimate for ALL, OR=7.78 (95% CI 1.33–45.5).
No dose-response effect was observed according to smoking exposure during pregnancy
and EAL. An association between secondhand smoking during pregnancy or breastfeed-
ing was not observed. Conclusion:An association between maternal smoking and EAL in
the offspring was restricted to women who have reported an intense exposure to tobacco
smoke during pregnancy and breastfeeding.
Keywords: smoking, pregnancy, childhood cancer, infant leukemia, lactation
INTRODUCTION
The current smoking prevalence worldwide reaches around one
billion persons (WHO, 2009). Epidemiologic research mainly con-
ducted since 1950 has identified a causal association between
tobacco smoking and lung cancer, as well as with 20 other tumor
types (Secretan et al., 2009), chronic bronchitis, and ischemic heart
diseases (Mackay and Eriksen, 2002).
In Brazil, data from a national population-based survey per-
formed in 2008 indicated that 17.2% of individuals >14 year
smoke, which represents about 25 million people (IBGE, 2008).
Some detailed etiological mechanisms on the association between
smoking and cancer remain unknown. Nevertheless, cigarette
smoke spread over than 4,000 chemicals and toxic metals, includ-
ing aluminum, ammonia, arsenic, benzene, DDT, dieldrin, carbon
monoxide, carbon dioxide, chloroform, formaldehyde, hydrogen,
lead, tar, and vinyl chloride. More than 40 of these chemicals are
known carcinogens (Hecht, 1999; Chang et al., 2006; Thielen et al.,
2008), 20 of them being probably involved in the induction of
lung cancer as observed in animal studies (Hecht, 1999), and 11
considered human carcinogens (IARC, 2004). Moreover, tobacco
smoke includes several chemicals which have been reported as
leukemogenic in the literature, such as benzene (Korte et al., 2000;
Hoffmann et al., 2001), pesticides (Rahman et al., 2012), arsenic
(Yang, 2011), and metals (Yang, 2011).
According to leukemogenesis, the cytochrome-P450 enzymes
family and NQO1 gene polymorphisms are involved in activation
of benzene and other xenobiotic metabolites, both participating in
benzoquinone detoxification and reactivating benzene intermedi-
ates (Zhang et al., 2010). Giving some support for an association
between smoking and leukemia, a study carried out in Japan
showed an increased risk for leukemia when occurring a joint
occupational exposure to benzene in the presence of the NQO1
enzyme homozygous polymorphism [odds ratio, OR= 7.6 (95%
CI 1.8–31.2; Rothman et al., 1997)].
Nicotine readily crosses the placenta and the fetal concentra-
tions are 15% higher than maternal levels (Lambers and Clark,
1996). Nevertheless, maternal exposure to smoking during preg-
nancy was not associated with an increased risk of leukemia in
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a North-American study (Chang et al., 2006). However, pater-
nal smoking during preconception showed statistically significant
high risk estimates for acute myeloid leukemia (AML), OR= 3.84
(95% CI 1.04–14.17). When combined with maternal exposure
during lactation, the study also found an increased ALL risk.
This study aimed to determine the magnitude of association
between maternal exposure to smoking during preconception,
pregnancy, and lactation, and the development of leukemia in
children under 2 year in Brazil.
MATERIALS AND METHODS
STUDY POPULATION
This investigation is part of a multicenter study named
“Multi-institutional Study of Infant Leukemia: Contribution of
Immunomolecular Markers in Distinguishing Different Etiopath-
ogenic Factors,” which focuses on the investigation of the patho-
genic mechanisms of early age leukemia (EAL) in Brazil (Pombo-
de-Oliveira and Koifman, 2006). Participants (n= 675) were chil-
dren<2 year, recruited from 15 different hospitals providing onco-
logic care,or general hospitals in all geographic areas in the country
but the Amazon, including cities in the South, the Southeast, the
Northeast, and the Midwest regions.
STUDY DESIGN
This is a hospital-based multicenter case-control study in which
controls were age frequency matched and paired by area of res-
idence with enrolled cases. Data were obtained by interviews
carried out with the respective patient mothers recruited in the
Brazilian national universal healthcare system hospitals, which
provide free care for pediatric patients either diagnosed with
cancer or other illnesses.
CASE AND CONTROLS ASCERTAINMENT
Cases (n= 252) were defined as children ≤24 month old with
a conclusive diagnosis of acute lymphoid leukemia (ALL) or
AML, confirmed by morphologic, immunophenotypical, and
cytogenetic-molecular standard methods. About 90% of ALL had
confirmatory immunophenotyping, and both ALL and AML had
been tested for specific lineage molecular diagnosis.
Controls (n= 423) were selected in the centers wherein
cases were recruited, or general hospitals settled in the same
cities, all belonging to the same age group and presenting
non-malignant diseases. In order to reduce recall bias, they
included hospitalized children with quite life-threatening con-
ditions presenting the following distribution: infectious and
parasitic diseases (n= 124, 29.4%); non-malignant hematolog-
ical diseases (n= 83, 19.6%); asthma and bronchitis (n= 43,
10.2%); hemangiomas (n= 40, 9.4%); severe diarrhea (n= 39,
9.2%); cardiovascular diseases (n= 25, 5.8%); and others (n= 69,
16.4%).
EXCLUSION CRITERIA
Cases and controls with congenital syndromes, myelodyspla-
sia, adoptive parents, or unknown biological mothers, were not
included in this study. Controls with malignant or other benign
tumor diagnosis were excluded.
DATA COLLECTION
The study was specifically designed to collect information on
environmental exposures potentially associated with leukemoge-
nesis. Data collection was gathered through face-to-face interview
with case and control mothers, after signing a written informed
consent. A standardized questionnaire containing the family’s
socioeconomic background, parents’ occupational history, health
antecedents, medicines use, as well as lifestyle patterns, includ-
ing smoking, alcohol consumption, and other environmental
exposures during pregnancy, was used.
Antecedents of reported maternal smoking were obtained,
including smoking status at interview (never, past, and current
smoking) and smoking during pregnancy. The latter included the
usual amount of daily smoked cigarettes during preconception,
pregnancy, and breastfeeding, and usual smoking frequency at
these time windows: no primary hand smokers; moderate smokers
(less than 20 smoked cigarettes per day); and heavy smokers (20
or more smoked cigarettes per day). Information on the lifelong
length of tobacco exposure (in years), secondhand smoking, and
smokers amount at home during pregnancy were also obtained.
ETHICAL ASPECTS
This study used primary data obtained from the project
“Multi-institutional Study of Infant Leukemia: Contribution of
Immunomolecular Markers in Distinguishing Different Etiopath-
ogenic Factors.” This investigation was approved by the Research
Ethics Committee of the Brazilian National Cancer Institute, No.
005/06.
STUDY POWER
The initial sampling ascertainment forecast a sample size of 576
individuals, according to 2:1 controls per case ratio, totaling 192
cases and 384 controls for the study population. With a power of
80%, a type I error α= 5%, the size of the study enabled to detect
minimum OR of 1.8 for an exposure prevalence among controls
of about 30%.
STATISTICAL ANALYSIS
Unconditional logistic regression was performed to estimate the
magnitude of association between maternal smoking and EAL,
being the respective OR and their 95% confidence intervals ascer-
tained after adjustment for selected variables (maternal age and
education, oral contraceptives use during pregnancy, birth weight,
and skin color) previously identified as confounders in the stud-
ied dataset (Pombo-de-Oliveira and Koifman, 2006). Considering
the inclusion of some controls with asthma and cardiovascu-
lar diseases, a sensitivity analysis was performed to evaluate the
overall impact of these participants in the ascertained association
measures.
RESULTS
The main socio-demographic participant characteristics reveal
statistically significant differences between cases and controls
regarding maternal age, skin color, education, and income
(Table 1). Thus, approximately 67% of cases were white (36% of
controls), 60% of case mothers were 25 year or older (43% among
controls), and 58% of the former reported school attendance of
8 years or more (49% among controls).
Frontiers in Oncology | Cancer Epidemiology and Prevention November 2012 | Volume 2 | Article 151 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ferreira et al. Pregnancy, smoking, and childhood leukemia
Table 1 | Distribution of selected maternal and child
socio-demographic variables, leukemia cases, and controls, children
<2 year, Brazil, 1999–2007.
Cases
(n=252), n (%)
Controls
(n=423), n (%)
p-Value
SEX
Male 130 (51.6) 226 (53.4) 0.643
Female 122 (48.4) 197 (46.6)
BIRTHWEIGHT (g)
<4000 234 (92.8) 393 (93.0) 0.470
>4000 16 (6.2) 21 (5.0)
SKIN COLOR
White 170 (67.5) 153 (36.2) <0.01
Non-White 77 (30.5) 256 (60.5)
PLACE OF BIRTH
Northeast 52 (20.6) 101 (24.1) 0.552
Midwest 18 (7.1) 31 (7.3)
Southeast 155 (61.5) 237 (56.0)
South 27 (10.7) 53 (12.5)
MATERNALAGEAT BIRTHa (YEARS)
<18 8 (3.2) 60 (14.1) <0.01
18–24 91 (36.1) 182 (42.9)
25–34 117 (46.4) 145 (34.2)
>35 36 (14.3) 36 (8.8)
MATERNAL EDUCATION (YEARS)
<8 81 (32.1) 206 (48.6) <0.01
>8 146 (57.9) 209 (49.4)
aMaternal age at delivery.
Maternal tobacco smoking during pregnancy was reported by
17.5% of case mothers and 20.6% of controls’. Among children
0–11 months, maternal smoking during the index pregnancy was
reported by 18.2% of ALL mothers, 17.9% of AML, and 23.1% of
control’s. According to children 11–23 months, these proportions
were, respectively, 20.0, 6.5, and 16.7%. Heavy smoking (20 or
more cigarettes daily) during the studied time windows of interest
was reported by nine (4.71%) of ALL mothers and four (0.9%) of
controls’ (Table 3).
No association between maternal smoking and ALL or AML
was observed according to the child age strata, 0–11 and 12–
23 months (Table 2). Considering the amount of daily smoked cig-
arettes, a statistically significant association was observed between
maternal daily consumption of 20 or more cigarettes and ALL,
adjusted (adj.) OR= 5.28, 95% CI 1.40–19.95 (Table 3). Never-
theless, no dose-response effect on the amount of smoked tobacco
and EAL was verified.
Enrolled children with a diagnosis of asthma (n= 18) and car-
diovascular diseases (n= 28) accounted for 10.8% of controls.
A sensitivity analysis was performed excluding them, and small
changes on the risk estimates were observed. For instance, the
magnitude of association between maternal heavy smoking dur-
ing the third trimester (Table 4) changed from adj. OR= 7.78,
95 CI 1.33–45.5 (all controls included) to adj. OR= 6.98, 95%
CI 1.21–40.4 (asthma and cardiovascular diseases excluded). A
similar pattern was observed for other time windows of exposure
(data not shown).
Not statistically significant increased EAL risk estimates asso-
ciated with a cumulative exposure to tobacco smoking were
observed for ALL in all quartiles of time length of tobacco
exposure. Comparatively to the first quartile (0–5 years) used
as reference, the following risk estimates were verified: adj.
OR= 1.43, 95% CI 0.29–7.06 in the second smoking quartile
(6–9 year); adj. OR= 1.24, 95% CI 0.21–7.43 in the third quar-
tile (10–14 year); adj. OR= 1.74, 95% CI 0.29–10.3 in the fourth
quartile [14 year or more, p-trend= 0.32 (Table 3)]. No asso-
ciation was also observed according to maternal secondhand
smoking.
DISCUSSION
Although smoking has historically been a predominantly male-
related behavior until the beginning of the twentieth century
(Einarson and Riordan, 2009), women’s liberation movement dur-
ing the 1960s and 1970s accelerated a lifestyle change, with smok-
ing increase among women in industrialized countries. Hence,
increasing rates of several smoking health related hazards among
women started to be observed in Brazil and other countries (Lom-
bardi et al., 2010). Such epidemiological change has stimulated the
organization of public policies toward smoking control programs
addressed to prevent such addiction among women (Amos et al.,
2012).
Eleven cigarette compounds were detected as human car-
cinogens and others may be carcinogenic, but have not been
yet fully evaluated (IARC, 2004). Tobacco smoke also contains
tumor promoters (phenolic substances), co-carcinogens (catechol
and related compounds), toxic agents (acrolein and other alde-
hydes), and free radical species (nitric oxide and others; IARC,
2004).
Even though, the role of parental prenatal smoking in child-
hood leukemia remains unknown. Nevertheless, such biological
plausibility is supported by the presence of carcinogenic chemi-
cals in tobacco smoke (IARC, 2004; Thielen et al., 2008), and their
ability to cross the placenta (de la Chica et al., 2005), to cause DNA
damage (Potts et al., 1999), oxidative damage (Fraga et al., 1996),
chromosomal abnormalities (Pluth et al., 2000), and aneuploidy
in human sperm (Shi et al., 2001).
Maternal tobacco smoking during pregnancy was reported in
this study by 17.5% of case mothers and 20.6% of controls’. Data
from a population-based national survey carried out in 2008
indicated that smoking prevalence in women 15 year or older
was 13.1% in Brazil (IBGE, 2008). According to other national
population-based survey with phone interviews, such figures are
higher in the South and Southeast of Brazil, wherein they range
around 22% among women, being lower in the Northeast, around
6% (Brazil, 2009).
The null association between maternal smoking and EAL risk
regardless the period of exposure during pregnancy, as observed in
this study, is consistent with the literature. The absence of an asso-
ciation between maternal smoking exposure and EAL according to
the child age strata in this investigation, does not support an asso-
ciation between the occurrence of MLL gene rearrangements as
a consequence of such exposure, considering the high prevalence
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Table 2 | Maternal smoking during pregnancy according to offspring age strata, leukemia cases, and control mothers, children <2 year, Brazil,
1999–2007.
Tobacco smoking
at pregnancy/
child age
Controls
(n=423),
n (%)
ALL
(n=193),
n (%)
AML
(n=59),
n (%)
ALL AML
OR ORAdjusteda OR ORAdjusteda
(95% CI) (95% CI) (95% CI) (95% CI)
MATERNAL SMOKING
0–11Months
No 196 (76.9) 72 (81.8) 23 (82.1) 1.00 1.00 1.00 1.00
Yes 59 (23.1) 16 (18.2) 5 (17.9) 0.74 (0.40–1.37) 0.65 (0.31–1.38) 0.72 (0.26–1.98) 0.41 (0.11–1.59)
12–23Months
No 140 (83.3) 84 (80.0) 29 (93.5) 1.00 1.00 1.00 1.00
Yes 28 (16.7) 21 (20.0) 2 (6.5) 1.25 (0.67–2.34) 1.38 (0.65–2.93) 0.35 (0.08–1.53) 0.46 (0.10–2.24)
TIMEWINDOW
Preconceptionb
0–11Months
No 176 (69.0) 59 (67.0) 20 (71.4) 1.00 1.00 1.00 1.00
Yes 79 (31.0) 29 (33.0) 8 (28.6) 0.89 (0.38–2.11) 1.23 (0.68–2.22) 1.10 (0.65–1.84) 0.82 (0.30–2.25)
12–23Months
No 128 (76.2) 79 (75.2) 27 (87.1) 1.00 1.00 1.00 1.00
Yes 40 (23.8) 26 (24.8) 4 (12.9) 1.05 (0.60–1.86) 0.98 (0.50–1.92) 0.47 (0.16–1.44) 0.42 (0.13–1.39)
First trimester
0–11Months
No 209 (82.0) 71 (80.7) 24 (85.7) 1.00 1.00 1.00 1.00
Yes 46 (18.0) 17 (19.3) 4 (14.3) 1.09 (0.59–2.02) 1.03 (0.49–2.18) 0.76 (0.25–2.29) 0.62 (0.16–2.34)
12–23Months
No 145 (86.3) 84 (80.0) 29 (93.5) 1.00 1.00 1.00 1.00
Yes 23 (13.7) 21 (20.0) 2 (6.5) 1.58 (0.82–3.02) 1.61 (0.74–3.51) 0.44 (0.10–1.95) 0.41 (0.08–2.09)
Second trimester
0–11Months
No 210 (82.4) 76 (86.4) 25 (89.3) 1.00 1.00 1.00 1.00
Yes 45 (17.6) 12 (13.6) 3 (10.7) 0.74 (0.37–1.47) 0.93 (0.43–2.02) 0.56 (0.16–1.94) 0.38 (0.08–1.83)
12–23Months
No 146 (86.9) 89 (84.8) 29 (93.5) 1.00 1.00 1.00 1.00
Yes 22 (13.1) 16 (15.2) 2 (6.5) 1.19 (0.60–2.39) 1.37 (0.61–3.07) 0.46 (0.10–2.05) 0.44 (0.09–2.29)
Third trimester
0–11Months
No 211 (82.7) 76 (86.4) 25 (89.3) 1.00 1.00 1.00 1.00
Yes 44 (17.3) 12 (13.6) 3 (10.7) 0.76 (0.38–1.51) 0.97 (0.45–2.11) 0.58 (0.17–1.99) 0.40 (0.08–1.91)
12–23Months
No 146 (86.9) 89 (84.8) 29 (93.5) 1.00 1.00 1.00 1.00
Yes 22 (13.1) 16 (15.2) 2 (6.5) 1.19 (0.60–2.39) 1.50 (0.66–3.41) 0.46 (0.10–2.05) 0.49 (0.09–2.57)
Breastfeedingc
0–11Months
No 209 (82.0) 77 (87.5) 26 (92.9) 1.00 1.00 1.00 1.00
Yes 46 (18.0) 11 (12.5) 2 (7.1) 0.65 (0.32–1.32) 0.90 (0.42–1.96) 0.35 (0.08–1.53) 0.39 (0.08–1.89)
12–23Months
No 148 (88.1) 88 (83.8) 29 (93.5) 1.00 1.00 1.00 1.00
Yes 20 (11.9) 17 (16.2) 2 (6.5) 1.43 (0.71–2.87) 1.86 (0.83–4.20) 0.51 (0.11–2.03) 0.69 (0.14–3.53)
aAdjusted OR by maternal age at birth, maternal education, oral contraceptives use during pregnancy, birth weight, and infant skin color.
bThree months before pregnancy.
cThree months after birth.
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Table 3 | Secondhand maternal smoking, cigarettes consumption amount and duration of tobacco exposure, leukemia cases, and control
mothers, children <2 year, Brazil, 1999–2007.
Smoking Controls
(n=423),
n (%)
ALL
(n=193),
n (%)
AML
(n=59),
n (%)
ALL AML
OR (95% CI) ORAdjusteda (95% CI) OR (95% CI) ORAdjusteda (95% CI)
SECONDHAND SMOKING
Non-smoker mothersb
No 168 (51.9) 81 (56.6) 32 (66.7) 1.00 1.00 1.00 1.00
Yes 156 (48.1) 62 (43.4) 16 (33.3) 0.82 (0.56–1.23) 0.96 (0.63–1.47) 0.54 (0.28–1.02) 0.66 (0.34–1.29)
FORMER SMOKER MOTHERSc
No 34 (38.6) 13 (24.1) 8 (50.0) 1.00 1.00 1.00 1.00
Yes 54 (61.4) 41 (75.9) 8 (50.0) 1.99 (0.93–4.23) 1.88 (0.81–4.34) 0.63 (0.22–1.84) 0.78 (0.22–2.75)
SMOKER MOTHERSd
No 15 (18.3) 4 (14.7) 2 (33.3) 1.00 1.00 1.00 1.00
Yes 67 (81.7) 29 (85.3) 4 (66.7) 1.29 (0.43–3.91) 1.62 (0.43–6.14) 0.45 (0.08–2.68) 0.67 (0.07–6.10)
EXPOSUREAMOUNT DURING PREGNANCYe (CIGARETTES PER)
No use 304 (71.9) 137 (71.0) 48 (81.4) 1.00 1.00 1.00 1.00
1–5 62 (14.7) 34 (17.6) 7 (11.9) 1.22 (0.77–1.94) 1.18 (0.70–2.02) 0.72 (0.31–1.65) 0.69 (0.27–1.74)
6–19 53 (12.5) 13 (6.7) 4 (6.8) 0.54 (0.29–1.03) 0.61 (0.30–1.24) 0.48 (0.17–1.38) 0.37 (0.11–1.28)
20 or more 4 (0.9) 9 (4.7) 0 (0.00) 4.99 (1.51–16.5) 5.28 (1.40–19.9) 0.00 0.00
p-trend=0.75
EXPOSURE LENGTH (YEARS)
0–5 18 (24.0) 3 (12.5) 1 (25.0) 1.00 1.00 1.00 1.00
6–9 21 (28.0) 7 (29.2) 1 (25.0) 2.00 (0.45–8.89) 1.43 (0.29–7.06) 0.86 (0.05–14.71) 0.51 (0.02–11.15)
10–14 16 (21.3) 6 (25.0) 1 (25.0) 2.25 (0.48–10.50) 1.24 (0.21–7.43) 1.13 (0.07–19.50) 1.00 (0.04–21.74)
15+ 20 (26.7) 8 (33.3) 1 (25.0) 2.40 (0.55–10.46) 1.74 (0.29–10.32) 0.90 (0.05–15.47) 0.22 (0.00–15.52)
p-trend=0.32
aAdjusted OR by maternal age at birth, maternal education, oral contraceptives use during pregnancy, birth weight, and infant skin color.
bNon-smoker mothers living with smokers.
cFormer smoker mothers living with smokers.
dSmoker mothers living with smokers.
eMean daily maternal cigarettes consumption during pregnancy.
of such rearrangements observed in infant leukemia (Marschalek,
2011).
On the other hand, an association between maternal smoking
during pregnancy and EAL cannot be completely ruled out, since
a statistically significant association was observed for heavy smok-
ers and ALL, adj. OR= 5.28, 95% CI 1.40–19.95. Hence, this study
results suggest that such association may occur, if the amount of
tobacco daily exposure remains high during pregnancy or immedi-
ately later. Nevertheless, it is important to remark that these results
were observed with few heavy smoker mothers (nine ALL and four
control mothers). Additionally, the variable smoking consump-
tion was highly correlated during the time windows of exposure
(Pearson correlation coefficients ranging from r = 0.66 between
preconception and breastfeeding, and r = 0.85 between the third
trimester and breastfeeding). In regard to secondhand smoking
during pregnancy, no association with EAL was observed.
A research published by IARC/WHO concluded that passive
smoke is carcinogenic (IARC, 2004), and smoke inhaled by pas-
sive smokers is responsible for tobacco-related diseases, especially
lung cancer (Hackshaw et al., 1997). Passive smoking may begin
during the intrauterine life, due to pregnant smokers, workplaces
and living with smokers, introducing toxic substances through
the umbilical cord to the fetus. Besides differences according to
carcinogenesis in early life, infants have distinct capacities from
adults to metabolize and clear chemicals, which can result in
larger or smaller internal doses of active agents, either increasing
or decreasing risk (Ginsberg et al., 2002).
A case-control study conducted in Australia (Milne et al., 2012)
examined the association between parental smoking and the risk
of childhood ALL. Maternal smoking was not associated with risk
of childhood ALL, but a performed meta-analyses suggested that
heavier paternal smoking around the time of conception is a risk
factor for childhood ALL (OR= 1.44, 95% CI 1.24–1.68).
A Canadian study observed an association between AML
and 10–19 cigarettes per day consumption during pregnancy,
OR= 3.89, 95% CI 1.31–11.58. The risk estimate for the same
intake during the first trimester was OR= 4.03, 95% CI 1.33–
12.21 (MacArthur et al., 2008). Conversely, two French studies
did not find an association between maternal smoking and child-
hood leukemia. The first one did not either observed an association
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Table 4 | Maternal smoking by tobacco consumption burden, leukemia cases, and control mothers, children <2 year, Brazil, 1999–2007.
Timing of expo-
sure/
smoking burden
Controls
(n=423),
n (%)
ALL
(n=193),
n (%)
AML
(n=59),
n (%)
ALL AML
OR (95% CI) ORAdjusteda (95% CI) OR (95% CI) ORAdjusteda (95% CI)
PRECONCEPTIONb
Non-smokers 304 (71.9) 137 (71.0) 47 (79.7) 1.00 1.00 1.00 1.00
Moderate smokers 109 (25.7) 45 (23.3) 11 (18.6) 0.92 (0.61–1.37) 0.93 (0.59–1.45) 0.65 (0.33–1.30) 0.59 (0.27–1.28)
Heavy smokers 10 (2.4) 11 (5.7) 1 (1.7) 2.44 (1.01–5.88) 2.52 (0.95–6.72) 0.65 (0.81–5.17) 0.80 (0.93–6.90)
FIRSTTRIMESTER
Non-smokers 354 (83.7) 154 (79.8) 53 (89.8) 1.00 1.00 1.00 1.00
Moderate smokers 65 (15.4) 33 (17.1) 5 (8.5) 1.17 (0.74–1.85) 1.10 (0.65–1.82) 0.51 (0.20–1.33) 0.44 (0.15–1.31)
Heavy smokers 4 (0.9) 6 (3.1) 1 (1.7) 3.45 (0.96–12.39) 3.35 (0.75–15.0) 1.67 (0.18–15.23) 2.70 (0.27–26.5)
SECONDTRIMESTER
Non-smokers 356 (84.2) 164 (85.0) 54 (91.5) 1.00 1.00 1.00 1.00
Moderate smokers 65 (15.4) 23 (11.9) 4 (6.8) 0.77 (0.46–1.28) 0.47 (0.02–0.92) 0.41 (0.14–1.16) 0.17 (0.01–2,14)
Heavy smokers 2 (0.4) 6 (3.1) 1 (1.7) 6.51 (1.30–32.0) 6.82 (1.09–4.30) 3.30 (0.30–37.0) 5.97 (0.47–76.0)
THIRDTRIMESTER
Non-smokers 357 (84.4) 165 (85.5) 54 (91.5) 1.00 1.00 1.00 1.00
Moderate smokers 64 (15.2) 22 (11.4) 4 (6.8) 0.74 (0.44–1.25) 0.96 (0.54–1.69) 0.41 (0.14–1.16) 0.43 (0.10–1.18)
Heavy smokers 2 (0.4) 6 (3.1) 1 (1.7) 6.49 (1.30–32.0) 6.81 (1.09–42.7) 3.30 (0.30–37.0) 6.03 (0.47–77.0)
BREASTFEEDINGc
No smokers 357 (84.4) 164 (85.0) 55 (93.2) 1.00 1.00 1.00 1.00
Moderate smokers 64 (15.2) 22 (11.4) 3 (5.1) 0.75 (0.45–1.26) 0.94 (0.53–1.66) 0.30 (0.09–1.00) 0.37 (0.11–1.28)
Heavy smokers 2 (0.4) 7 (3.6) 1 (1.7) 7.62 (1.57–32.0) 7.78 (1.33–45.5) 3.25 (0.29–36.4) 6.05 (0.47–77.0)
aAdjusted OR by maternal age at birth, maternal education, oral contraceptives use during pregnancy, birth weight, and infant skin color.
bThree months before pregnancy.
cThree months after birth.
before, or during pregnancy, or during childhood (Menegaux et al.,
2007). The other study did not detect an association regardless
the maternal period of smoking during pregnancy (Menegaux
et al., 2005). In a national registry-based case-control carried out
in France (Rudant et al., 2008), an association between maternal
smoking and childhood leukemia was also not observed. In this
sense, only few studies have found maternal smoking to be sig-
nificantly associated with the risk of ALL (Sorahan et al., 2001;
MacArthur et al., 2008).
The analyzed data in the current investigation were strictly
dependent on a maternal report, which may have introduced
incorrect exposure estimates, being over or underreported. Never-
theless, we believe that whether this lack of accuracy has occurred,
it probably was non-differential, considering the use of a stan-
dardized questionnaire and interview procedures to get infor-
mation from case and control mothers, which decreases the
potential differential misclassification. Thus, we consider that
the observed results are not likely to be explained by underre-
porting smoking controls, since the proportion of mothers who
reported to have smoked during the study was higher than the
average percentage of Brazilian population in 2003 (18.4%) and
2008 (13.1%; Wunsch Filho et al., 2010). However, mothers of
reported cases may have been not exposed to their own ciga-
rettes, thus reducing the chance to produce an observable asso-
ciation. On the other hand, Menegaux et al. (2005) suggested
that the general feeling of guilty associated with smoking may be
stronger in mothers of children with leukemia than among con-
trol’s, arising unequal accuracy of information provided by the
former.
Most of the literature reveals a relationship between the risk
of childhood leukemia and paternal smoke around the time of
conception, probably due to its influence in spermatogenesis (Shu
et al., 1996; Pang et al., 2003; Chang et al., 2006; Rudant et al.,
2008; Lee et al., 2009; Milne et al., 2012). In this investigation,
paternal smoking data was not obtained. Therefore, evaluation
whether the offspring of heavy smoker mothers – showing higher
EAL risk estimates – also had smoker fathers, was unfeasible to be
accomplished.
Maternal smoking during pregnancy has been associated to
several health hazards, including spontaneous abortion, infer-
tility, and sudden infant death syndrome, among several others
(Einarson and Riordan, 2009). A higher incidence of spontaneous
abortion among case mothers, comparatively to controls’, could
yield to a null association between smoking and leukemia. If true,
however, such fact would mainly target heavy smoker pregnants,
and a null association would mainly occur in their offspring, which
was not observed. Additionally, it is possible that heavy smoker
mothers were less likely to be included in the current study as a
consequence of the association between smoking with abortion
and infertility.
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In the current investigation, the choice of hospitalized con-
trols with severe diseases may have probably mitigated the occur-
rence of such kind of bias. Controls were selected from the
same regions wherein cases came from, as a procedure to assure
that the study base principle could be accomplished, i.e., that
all enrolled participants could share the background pattern of
exposures, thus allowing to obtain unbiased risk estimates with
the performed comparisons (Wacholder et al., 1992). Finally,
according to AML, the relatively small amount of enrolled cases
in this study did not allow the ascertainment of some risk
estimates.
This investigation presented some weaknesses. At first, sam-
ple size of AML cases limited data exploratory analysis. Secondly,
considering the high correlation among the reported smoking
prevalence in the different time windows of exposure, the obtained
risk estimates in each of them are probably imprecise, and they
need to be interpreted cautiously. Thirdly, data on paternal smok-
ing before and during pregnancy was not collected during the
interviews.
Nevertheless, the study presents some strengths. At first, it was
feasible to collect maternal data exposure to smoking in a very
rare cancer, such as leukemia in children under 2 year. At such age
strata, with a short postnatal life span of exposures, the importance
of in utero environmental exposures is of paramount importance,
and the investigation was able to either obtain a detailed report
about timing and amount of tobacco (smoked cigarettes) exposure
during pregnancy, or other important risk factors, such as birth
weight and oral contraceptives use during the same period. Finally,
to our knowledge, this is the first Latin American study exploring
the association between maternal smoking during pregnancy and
leukemia among children under 2 year.
Consistent with most previous studies (Menegaux et al., 2005,
2007), this study did not report an association between maternal
smoking and EAL. This result is in agreement with a possible lower
maternal contribution to the risk of embryonic genetic mutations,
comparatively to paternal one. Such observation can result to the
fact that the ova are formed and stored in the female embryo, being
better protected against genotoxic stress, while the male germ cells,
keeps the process continuously (Guerquin et al., 2009). However,
maternal daily consumption of 20 or more cigarettes during preg-
nancy showed a fivefold higher statistically significant association
with the risk of ALL. Such risk estimates are indeed higher if con-
sidered such exposure during the second trimester of pregnancy,
the third trimester, or breastfeeding.
To conclude, this investigation results observed the occur-
rence of an association between an intensive exposure to tobacco
smoking during pregnancy and AAL, being higher if such expo-
sure occurred after the first trimester of pregnancy, including
breastfeeding.
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APPENDIX
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